Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study)

Background. Dupilumab, a fully human monoclonal antibody directed against the common -subunit of interleukin (IL)-4 receptors and blocking signaling from both IL-4 and IL-13, may be recommended for the treatment of moderate to severe atopic dermatitis (AD) and bronchial asthma (BA). Aim. To perfo...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Daria S. Fomina, Sergey V. Fedosenko, Elena N. Bobrikova, Anton A. Chernov, Olga A. Mukhina, Marina S. Lebedkina, Alexander V. Karaulov, Asel Yu. Nurtazina, Mariana A. Lysenko
Materiálatiipa:	Artigo
Giella:	Russo
Almmustuhtton:	"Consilium Medicum" Publishing house 2023-09-01
Ráidu:	Терапевтический архив
Fáttát:	severe asthma t2-asthma atopic dermatitis dupilumab targeted therapy biological therapy
Liŋkkat:	https://ter-arkhiv.ru/0040-3660/article/viewFile/595928/135402
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!